Global Gangrene Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Type;

Dry Gangrene, Wet Gangrene, Gas Gangrene, and Others.

By Treatment;

Vascular Surgery, Hyperbaric Oxygen Chamber, Amputation, and Others.

By End User;

Hospitals, Clinics, Rehabilitation Center, and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn132900113 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Gangrene Market (USD Million), 2021 - 2031

In the year 2024, the Global Gangrene Market was valued at USD 1,834.76 million. The size of this market is expected to increase to USD 3,223.35 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 8.4%.

The global gangrene market represents a critical area of medical concern, encompassing a range of conditions characterized by tissue death due to inadequate blood supply or bacterial infection. Gangrene poses significant challenges to healthcare systems worldwide, with its prevalence linked to various factors including diabetes, peripheral artery disease, trauma, and infections. As the incidence of risk factors such as diabetes continues to rise globally, the burden of gangrene is expected to escalate, necessitating comprehensive strategies for prevention, diagnosis, and treatment.

Effective management of the global gangrene market requires a multifaceted approach, integrating advancements in medical technology, pharmacotherapy, and surgical interventions. Early detection and prompt intervention are crucial in preventing the progression of gangrene and mitigating associated complications, which can include sepsis and limb loss. Moreover, addressing underlying risk factors through lifestyle modifications, improved wound care practices, and targeted therapies is essential in reducing the incidence and severity of gangrene-related complications.

The landscape of the global gangrene market is characterized by ongoing research and development endeavors aimed at enhancing diagnostic accuracy, therapeutic efficacy, and patient outcomes. Collaborative efforts between healthcare providers, researchers, and pharmaceutical companies play a pivotal role in driving innovation and advancing treatment modalities for gangrene. By fostering interdisciplinary collaborations and leveraging emerging technologies such as telemedicine and regenerative medicine, stakeholders can better address the complex challenges posed by gangrene and improve the quality of care for affected individuals worldwide.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Type
    2. Market Snapshot, By Treatment
    3. Market Snapshot, By End User
    4. Market Snapshot, By Region
  4. Global Gangrene Market Dynamics
    1. Drivers, Restraints and Opportunities
    2. Drivers
      1. Aging Population
      2. Increasing Diabetes Prevalence
      3. Rising Awareness
    3. Restraints
      1. Limited Healthcare Access
      2. Lack of Awareness in Underserved Areas
      3. High Treatment Costs
    4. Opportunities
      1. Advancements in Wound Care Technology
      2. Telemedicine Integration
      3. Collaborative Research Efforts
    5. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    6. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Gangrene Market, By Type, 2021 - 2031 (USD Million)
      1. Dry Gangrene
      2. Wet Gangrene
      3. Gas Gangrene
      4. Others
    2. Global Gangrene Market, By Treatment, 2021 - 2031 (USD Million)
      1. Vascular Surgery
      2. Hyperbaric Oxygen Chamber
      3. Amputation
      4. Others
    3. Global Gangrene Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Clinics
      3. Rehabilitation Center
      4. Others
    4. Global Gangrene Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Advanced Medical Solutions Group Plc
      2. Advanced Tissue
      3. Baril Corporation
      4. Cardinal Health
      5. Covalon Technologies Ltd
      6. Integra LifeSciences Corporation
      7. MediPurpose Private Limited
      8. McKesson Corporation
      9. TRIAGE MEDITECH PVT. LTD
  7. Analyst Views
  8. Future Outlook of the Market